Grail (GRAL) Liabilities and Shareholders Equity (2023 - 2026)
Grail's (GRAL) quarterly Liabilities and Shareholders Equity came in at $2.8 billion in Q1 2026, down 1.55% YoY from $2.8 billion in Q1 2025, and down 4.06% on a QoQ basis from $2.9 billion in Q4 2025.
Grail (GRAL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Grail (GRAL) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $2.8 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 1.55% year-over-year to $2.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 billion (down 9.73% YoY) and the FY2025 annual result came in at $2.9 billion, down 2.05% from the prior year.
- Liabilities and Shareholders Equity fell to $2.8 billion in Q1 2026, from $2.9 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.9 billion in Q4 2023 to a low of $2.6 billion in Q3 2025.
- A 4-year average of $3.0 billion and a median of $2.9 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity declined 23.77% — and 2026, when it fell 1.55%.
- Tracing GRAL's Liabilities and Shareholders Equity over 4 years: stood at $3.9 billion in 2023, then declined by 23.77% to $3.0 billion in 2024, then dropped by 2.05% to $2.9 billion in 2025, then declined by 4.06% to $2.8 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $2.8 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 113.17 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 92.37 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 3.44 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 13.07 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 29.88 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.65 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.67 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 16.94 Bn |
| 10 | Grail | 3.01 Bn | 2.19 Bn | 19.54 Mn | 2.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.80 Bn |
| Dec 31, 2025 | 2.92 Bn |
| Sep 30, 2025 | 2.60 Bn |
| Jun 30, 2025 | 2.70 Bn |
| Mar 31, 2025 | 2.85 Bn |
| Dec 31, 2024 | 2.98 Bn |
| Sep 30, 2024 | 3.12 Bn |
| Jun 30, 2024 | 3.27 Bn |
| Dec 31, 2023 | 3.91 Bn |